idarubicin has been researched along with lenvatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, W; Li, F; Li, J; Qiao, L; Tang, Y; Wang, H; Wu, Y; Xue, M; Yue, S; Zheng, X; Zhu, B; Zou, X | 1 |
1 other study(ies) available for idarubicin and lenvatinib
| Article | Year |
|---|---|
Idarubicin-Loaded DEB-TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score-matching analysis.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Idarubicin; Liver Neoplasms; Propensity Score; Retrospective Studies | 2023 |